Payers, Providers, and Patients – Oh My! cover art

All Episodes

Payers, Providers, and Patients – Oh My! — 52 episodes

#
Title
1

The No Surprises Act's Independent Dispute Resolution Process & 2026 Updates

2

Organ Procurement Overview & Updates

3

AI in Healthcare – Key Policy Developments and State Laws

4

The ABCs of Administrative Law – Administrative Law in the Health Care Industry (Part 2)

5

The ABCs of Administrative Law – Administrative Law in the Health Care Industry (Part 1)

6

World Elder Abuse Awareness Day

7

Gender-Affirming Care

8

Presidential Health Care Proposals

9

The New MHPAEA Final Rule – Key Takeaways and Insights

10

AI in Health Care Series, Part 3: The EU AI Act

11

AI in Health Care Series, Part 2: Artificial Intelligence, HIPAA and Data Privacy

12

AI in Health Care Series, Part 1: AI Use in Clinical Research Institutions

13

The Past, Present, and Future of Private Equity’s Role in Health Care

14

Enabling Widespread Adoption of Decentralized Clinical Trials

15

The Increasing Focus on Mental Health Parity

16

Hidden Costs of FCA and AKS Claims

17

Industry Views on the Trusted Exchange Framework and Common Agreement

18

How to Structure an Affirmative Recovery Program

19

More Changes to Section 1557 Nondiscrimination Rules

20

The Shrinking Medical Loss Ratio Numerator

21

Massive Federal Investment in Mental Health

22

Crowell Health Solutions Mini-Series Part 2 – A Health System’s Perspective on Prioritizing Health Equity

23

Shared-Risk Arrangements in California

24

Crowell Health Solutions Mini-Series Part 1 - The Intersection of Technology and Value-Based Care

25

What to Expect in Healthcare Transactions in 2022

26

What Health Care Companies Should Know about Developments in FCA Litigation

27

Reflecting on the First Year of the 2020 Stark & AKS Regulations

28

The New World of Health Data Interoperability

29

How Health Plans Can Address Social Determinants of Health

30

Business and Clinical Considerations for the Ketamine Industry

31

Recent Mental Health Parity Enforcement Activities

32

The ACA Risk Corridors Case

33

Data Analytics and FCA Investigations

34

Rating in the Time of COVID

35

ERISA Preemption of State PBM Regulation

36

Bostock and HHS’s Nondiscrimination Regulations

37

Who CARES: The Provider Relief Fund and Other CARES Act Provisions

38

What Providers Should Know about COVID-19 (Part 2 – Federal and State Guidance)

39

What Providers Should Know about COVID-19 (Part 1 – Labor and Employment Issues)

40

Medical Loss Ratios (Part 2)

41

Medical Loss Ratios (Part 1)

42

Digital Health Innovation

43

Multi-State Plan Program

44

Pharmacy Benefit Managers

45

Payers, Providers, and Patients – Oh My!: FDA Digital Health Guidance

46

Medicare Advantage Supplemental Benefits

47

Removal under ERISA

48

Some Potential Impacts of Legal Challenges to the ACA

49

Health Care Compliance Programs

50

Private Equity Investing in Health Care

51

Fiduciary Duties Under ERISA

52

FCA Dismissals Under the Granston Memo